SEC Form 4 · accession 0001209191-17-007325
NEUROCRINE BIOSCIENCES INC · NBIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David-Alexandre C Gros
Officer — President & COO
Period of report
Feb 1, 2017
Accepted (ET)
Feb 2, 2017 · 7:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000914475
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $42.55 | Feb 1, 2017 | A | 350,000 | A | — | Feb 1, 2027 | Common Stock | 350,000 | 350,000 | D |
Explanation of responses
- F1Represents option of which 1/4th of the shares underlying the option becomes vested and exercisable on February 2, 2018 and an additional 1/48th of the shares underlying the option becomes vested and excercisable each month thereafter.